SCHEMBL538380

SCHEMBL538380

COc1cc2c(cc1OC)C(c1ccccc1Cl)NCC2

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.71
MEN1 O00255 3/20 0.71
ALDH1A1 P00352 2/20 0.57
LMNA P02545 1/20 0.57
MAOA P21397 2/20 0.56
TSHR P16473 1/20 0.56
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA7 P43166 1/20 0.55
CA9 Q16790 1/20 0.55
CA14 Q9ULX7 1/20 0.55
DRD1 P21728 1/20 0.55
DRD5 P21918 1/20 0.55
GAA P10253 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.52
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
GRIN2D O15399 1/20 0.48
GRIN3B O60391 1/20 0.48
GRIN1 Q05586 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11713631 0.87 KMT2A (0.66) KMT2AMEN1ALDH1A1LMNAMAOA
SCHEMBL11713664 0.84 KMT2A (0.73) KMT2AMEN1ALDH1A1LMNAMAOA
SCHEMBL11710065 0.83 KMT2A (0.71) KMT2AMEN1ALDH1A1LMNAMAOA
SCHEMBL14646680 0.81 KMT2A (1.00) KMT2AMEN1ALDH1A1LMNAMAOA
SCHEMBL7849270 0.81 KMT2A (1.00) KMT2AMEN1ALDH1A1LMNAMAOA
SCHEMBL13804033 0.81 KMT2A (1.00) KMT2AMEN1ALDH1A1LMNAMAOA
SCHEMBL30789059 0.81 KMT2A (0.68) KMT2AMEN1ALDH1A1LMNAMAOA
SCHEMBL11714295 0.80 KMT2A (0.67) KMT2AMEN1ALDH1A1LMNAMAOA
Hydrochloric Acid SCHEMBL4772373 0.80 KMT2A (0.97) KMT2AMEN1ALDH1A1LMNAMAOA
SCHEMBL16979273 0.80 KMT2A (0.67) KMT2AMEN1ALDH1A1LMNAMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343961-B2 Substituted heterocyclic compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343961-B2 Substituted heterocyclic compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343961-B2 Substituted heterocyclic compounds ARQULE, INC. (US) 2013-01-01 US disclosed
EP-2414361-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS ArQule, Inc. (US) 2012-02-08 EP disclosed
WO-2010114894-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
WO-2010114894-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249115-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249115-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249115-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-4001244-A 1-ARYL-3,4-DIHYDRO-2(1H)-ISOQUINOLINE CARBONYL CHLORIDES G. D. SEARLE & CO. (US) 1977-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249115-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS CYP11B2, GABBR1, CNR1 KMT2A 628/4885MEN1 402/4885ALDH1A1 931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.